The little blue pill best known for treating erectile dysfunction may have a new, far more serious job: stopping cancer in its tracks. Researchers in the United States have found that sildenafil, the active ingredient in Viagra, appears to interfere with the spread of cancer cells, a process known as metastasis.
How a sex drug could block cancer’s escape route
Scientists at the University of Texas Health Science Center at Houston and the University of Texas MD Anderson Cancer Center conducted the study. They focused on the way cancer cells move through the body. When tumors grow, they release cells that travel through the bloodstream to form new tumors elsewhere. That process is what makes cancer deadly.
The team discovered that sildenafil disrupts a protein called CD44, which cancer cells use to latch onto blood vessel walls and squeeze through into new tissues. By blocking that grip, the drug may prevent cancer cells from leaving the bloodstream and settling in new organs. The findings were published in the journal Cell Reports Medicine.
Tests in mice and human tissue show real effects
The researchers tested sildenafil on mice with breast cancer and melanoma. They found that the drug reduced the number of metastatic tumors in the lungs. In lab experiments using human tissue samples, sildenafil also lowered the ability of cancer cells to invade healthy tissue.
Importantly, the doses used in the study were comparable to those taken by humans for erectile dysfunction. That means the drug is already known to be safe at those levels. The researchers emphasized that sildenafil is not a cure for cancer and does not shrink existing tumors. Its potential lies in stopping the spread, which could give patients more time and make other treatments more effective.
Why this matters to people facing cancer
For patients and their families, the possibility of using an existing, inexpensive drug to slow metastasis is significant. Metastasis is responsible for about 90 percent of cancer deaths. If a drug already approved by regulators can help prevent that, it could change how doctors approach treatment.
The researchers plan to move toward clinical trials in humans. They caution that people should not start taking Viagra on their own to fight cancer. But the study opens a door to repurposing a well known medication for a completely new purpose.
A drug that has sat in medicine cabinets for decades may turn out to have a second life in the fight against one of the world’s deadliest diseases.
